The Accelerating Innovation for Mothers (AIM) project – spearheaded by the Concept Foundation and delivered in partnership with Policy Cures Research and Burnet Institute – was created with the aim of fostering greater investment in and development of critical maternal health medicines for five significant pregnancy-related conditions, where biomedical product gaps exist:
- Preterm labour/birth
- Intrauterine growth restriction
- Postpartum haemorrhage
- Intrapartum foetal distress
As part of this work, Policy Cures Research created a current and historical landscape of medicines research and development (R&D) for these five conditions, which are included in the interactive product pipeline below. Alternatively, you can download the Excel version here as well as the report detailing the findings.